Wednesday, March 4, 2026

Latest:

CMS to suspend enrollment into Elevance’s Medicare Advantage plans
‘We’re running in when others are running out’: Stability drives record growth for regional Medicare Advantage plans
Even Patients Are Shocked by the Prices Their Insurers Will Pay — And It Costs All of Us
The gap between early retirement and Medicare eligibility
Where ACA premiums have risen most for older adults following expiration of enhanced subsidies

Part D/Prescription Drugs

Median estimated out-of-pocket costs for 30 specialty-tier drugs in 2019

(By Kelly Gooch for Becker’s Hospital Review) Medicare Part D beneficiaries with serious health conditions and not receiving low-income subsidies

(By Ike Swetlitz and Nicholas Florko for STAT) WASHINGTON — The Trump administration on Thursday put forth a long-awaited proposal

(Source – www.cms.gov/newsroom) Today, the Centers for Medicare & Medicaid Services (CMS) released proposed changes that will take significant steps

(By David Armstrong – ProPublica co-published by STAT) Not content with billions of dollars in profits from the potent painkiller

(By Emmarie Huetteman and Rachel Bluth for Kaiser Health News) Senators railed against pharmaceutical executives Tuesday for declining to testify

(By Alia Paavola for Becker’s Hospital Review) AstraZeneca has agreed to a pay-for-performance deal with UPMC Health Plan, according to STAT.

(By Alex M. Azar II for STAT) Two years ago this month, President Trump promised the American people that he would stop

(By Rhitu Chatterjee for NPR) The percentage of outpatient medical visits that led to a benzodiazepine prescription doubled from 2003 to 2015,

(By Alia Paavola for Becker’s Hospital Review) Civica Rx, the nonprofit generic drug company formed by a group of hospital

(By Shefali Luthra for Kaiser Health News) The next presidential primary contests are more than a year away. But presumed